IMMUNOME

What this means for you

Registered since 18 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Aug 2032: the §8 declaration of use).

Record

Serial number

98778646

Registration number

8404176

Mark type

Design + words

Filed

30 Sept 2024

Published for opposition

10 Jun 2025

Registered

18 Aug 2026

Next maintenance filing

§8 declaration of use, due by 18 Aug 2032 (grace period to 18 Feb 2033)

Attorney of record

Lori J. Shyavitz, Esq.

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
• Class 042 — Scientific and technological services: Biotechnology services, namely, development of monoclonal antibodies and antibody drug conjugates; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals

Owner

• Immunome, Inc., Bothell, WA, US
• Immunome, Inc., Bothell, WA, US
• Immunome, Inc., Bothell, WA, US

Prosecution history

• 18 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
• 28 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 28 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 30 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
• 07 Apr 2026 — USE AMENDMENT FILED
• 07 Apr 2026 — TEAS STATEMENT OF USE RECEIVED
• 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Jun 2025 — PUBLISHED FOR OPPOSITION
• 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 07 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 21 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
• 21 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 21 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
• 21 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN